| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $300K | +0.0% |
| R&D Expense | $79.3M | +36.2% |
| SG&A Expense | $28.8M | -25.0% |
| Operating Income | -$108.1M | -12.1% |
| Interest Expense | $0 | -100.0% |
| Income Tax | $0 | — |
| Net Income | -$106.5M | -11.6% |
| EPS (Basic) | -$2.74 | +0.7% |
| EPS (Diluted) | -$2.74 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $215.5M | -12.0% |
| Current Assets | $220.4M | -10.9% |
| Total Assets | $225.7M | -11.3% |
| Current Liabilities | $23.1M | +16.7% |
| Total Liabilities | $45.4M | +4.1% |
| Stockholders' Equity | $180.3M | -14.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$90.4M | -45.3% |
| Investing Cash Flow | -$265K | +71.3% |
| Financing Cash Flow | $61.2M | -11.9% |
| +0.7% |